Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by Chianchinon Mar 27, 2023 5:12pm
286 Views
Post# 35363335

GUD implied promises on past Paladin success

GUD implied promises on past Paladin success Regretably the Paladin Jeene did show up and the lamp went dark. The share price capitulation will continue as I "suspect" GUD MNGT has come to relize that keeping GUD share price above $5 has cost shareholders fortunes and is n longer sustainablle to overpay. What may come next? Firs all the promoters are running broke and no one would take ther advise to buy more of GUD after losing fortunes for 10 years. When and if the share price come arround $2 MNGT may go foer the exit door and a new capable MNGT takes over  and or some big wheel may take GUD private. One billion in cash and 10  later there are no more promises. I am surprised that MNGT and the BOD are hanging arround still. Meir knew well the faith to come for the limping knight. No one want to beleive him. 
Out for now  
<< Previous
Bullboard Posts
Next >>